SEPTInvestingStart Free

CYCN SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on · accession 0000315066-26-002345

CYCN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 7, 2026. An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Korsana Biosciences (KRSA).

Summary of the filing

An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Korsana Biosciences (KRSA). The filing indicates a change in the holder's ownership stake, though specific details are not disclosed in the available text.

For details, click here →

Key details

IssuerKorsana Biosciences, Inc.

✦ Ask GOAX AI about this filing — what it means for CYCN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CYCN?

Click here

Frequently asked questions

What did CYCN file with the SEC on Oct 7, 2026?

CYCN filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Korsana Biosciences (KRSA). The filing indicates a change in the holder's ownership stake, though specific details are not disclosed in the available text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other CYCN SEC filings

Get alerts when CYCN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
CYCN overviewCYCN analysisCYCN newsLatest SEC filings